← Back to Search

Other

Hearing aid for Sensorineural Hearing Loss (DIRWDRCWM Trial)

N/A
Waitlist Available
Led By Varsha Rallapalli, AuD, PhD
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Normal or corrected-to-normal vision (<=20/50)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights

DIRWDRCWM Trial Summary

This trial will test if working memory affects how people react to hearing aid settings, to better help those with hearing impairments.

Eligible Conditions
  • Sensorineural Hearing Loss

DIRWDRCWM Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You have normal or near-normal vision (at least 20/50 or better).

DIRWDRCWM Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Speech intelligibility (percent correct scores)

DIRWDRCWM Trial Design

4Treatment groups
Experimental Treatment
Group I: Setting 4Experimental Treatment1 Intervention
Hearing aid features presented in this arm include directional microphone settings and slow-acting compression
Group II: Setting 3Experimental Treatment1 Intervention
Hearing aid features presented in this arm include directional microphone settings and fast-acting compression
Group III: Setting 2Experimental Treatment1 Intervention
Hearing aid features presented in this arm include omnidirectional microphone settings and slow-acting compression
Group IV: Setting 1Experimental Treatment1 Intervention
Hearing aid features presented in this arm include omnidirectional microphone settings and fast-acting compression
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Hearing aid
2023
N/A
~1370

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor
1,576 Previous Clinical Trials
911,891 Total Patients Enrolled
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
324 Previous Clinical Trials
178,057 Total Patients Enrolled
Varsha Rallapalli, AuD, PhDPrincipal Investigator - Northwestern University
Northwestern University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available vacancies for enrolment in this trial?

"This particular clinical trial is presently recruiting participants, according to the information published on clinicaltrials.gov. The initial posting date was May 6th 2021 and its most recent update occurred November 10th 2022."

Answered by AI

What is the size of the cohort participating in this research trial?

"Affirmative. Clinicaltrials.gov indicates that this clinical trial is currently enrolling individuals, with the original advertisement being released on May 6th 2021 and amended on November 10th 2022. This study necessitates 120 participants from a solitary centre to begin trials."

Answered by AI
~16 spots leftby Mar 2025